A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer.
PLoS Biol
; 21(9): e3002295, 2023 09.
Article
en En
| MEDLINE
| ID: mdl-37713380
Cancer stem cells drive tumor growth and survival via self-renewal and therapeutic resistance, but the upstream mechanisms are not well defined. In this issue of PLOS Biology, a study in colon cancer reveals a new signalling network that links epigenetic regulation to these phenotypes.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias del Colon
/
Resistencia a Antineoplásicos
Límite:
Humans
Idioma:
En
Año:
2023
Tipo del documento:
Article